| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/26/2006 | WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | WO2006054629A1 1-SUBSTITUTED-3-β-D-GLUCOPYRANOSYLATED NITROGENOUS HETERO- CYCLIC COMPOUNDS AND MEDICINES CONTAINING THE SAME |
| 05/26/2006 | WO2006053700A1 Agonists and antagonists of the somatostatin receptor |
| 05/26/2006 | CA2588963A1 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 05/26/2006 | CA2588776A1 Substituted amino carboxylic acids |
| 05/26/2006 | CA2588766A1 Heterocycle substituted carboxylic acids |
| 05/26/2006 | CA2588513A1 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/26/2006 | CA2586612A1 Triazole compounds that modulate hsp90 activity |
| 05/26/2006 | CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | CA2582384A1 Agonists and antagonists of the somatostatin receptor |
| 05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
| 05/25/2006 | US20060111420 Sorbicillactone-a derivatives for the treatment of tumour and viral diseases |
| 05/25/2006 | US20060111419 Novel fused indazole compounds |
| 05/25/2006 | US20060111401 Taxanes having a C10 carbonate substituent |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111367 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide |
| 05/25/2006 | US20060111364 Reversible inhibitors of cysteine proteases S, K, F, L and B; N-[2-(Benzylamino)pyrimidin-4-yl]-N-(cyanomethyl)-L-phenylalaninamide |
| 05/25/2006 | US20060111360 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | EP1659111A2 Piperidine derivatives useful as ccr5 antagonists |
| 05/24/2006 | EP1658283A2 Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| 05/24/2006 | EP1658282A1 Novel chelating agents and chelates and their use |
| 05/24/2006 | EP1658270A1 Novel 6-phenylphenantridines |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | EP1508333B1 Novel therapeutic use of riboside of 5-aminoimidazole-4- carboxamide (acadesine) |
| 05/24/2006 | EP1506185B1 Compounds and their use as inhibitors of 5-ht |
| 05/24/2006 | EP1501812A4 Pna monomer and precursor |
| 05/24/2006 | EP1406888B1 Substituted y-lactone compounds serving as nmda antagonists |
| 05/24/2006 | EP1320529B1 Quinoline derivatives as antibacterials |
| 05/24/2006 | EP1254904B1 Novel piperidine compounds and drugs containing the same |
| 05/24/2006 | EP1226129B1 Methods and compositions utilizing quinazolinones |
| 05/24/2006 | DE102004055998A1 Niedermolekulare Inhibitoren von Guaninnucleotid-Austauschfaktoren der Cytohesin-Familie Small-molecule inhibitors of guanine nucleotide exchange factors of the cytohesin family |
| 05/24/2006 | CN1777601A Nk-2 antagonist basic linear compounds and formulations containing them |
| 05/24/2006 | CN1777596A Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 05/24/2006 | CN1777595A Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/24/2006 | CN1777585A 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 05/24/2006 | CN1777432A Anti-viral nucleoside analogs and methods for treating viral infections,especially HIV infections |
| 05/24/2006 | CN1777427A Aminoheteroaryl compounds as protein kinase inhibitors |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/23/2006 | US7049447 Aziridine derivatives and their preparation methods |
| 05/23/2006 | US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 05/23/2006 | US7049443 Such as 2-(3-(Acetyl(((5S)-3-(4-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-3 -fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl)meth yl)amino)-1,1-dimethyl-3-oxopropyl)-3,5-dimethylphenyl dihydrogen phosphate; improved bioavailability |
| 05/23/2006 | US7049438 Quinazoline derivatives for treatment of tumours |
| 05/23/2006 | US7049334 Enhancement of learning and memory and treatment of amnesia |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049310 Therapy for bacteria infections |
| 05/23/2006 | US7049309 Administering a therapeutically effective amount of 3-thia-4-(2-oxy/hydroxyphenyl)quinolin-2-one derivative to a patient to treat erectile dysfunction or irritable bowel syndrome |
| 05/23/2006 | US7049308 For therapy of inflammatory or painful disorder |
| 05/23/2006 | US7049307 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7048876 Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm. |
| 05/23/2006 | CA2257200C Substituted imidazoles having cytokine inhibitory activity |
| 05/23/2006 | CA2242494C Novel n-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
| 05/23/2006 | CA2232141C Substituted tetracyclic tetrahydrofuran derivatives |
| 05/23/2006 | CA2222724C 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds |
| 05/23/2006 | CA2158454C Taxanes having furyl or thienyl substituted side-chain |
| 05/23/2006 | CA2122270C Tri-substituted tetrahydrofuran antifungals |
| 05/18/2006 | WO2006053112A1 Process for preparing trisubstituted pyrimidine compounds |
| 05/18/2006 | WO2006052630A1 Therapeutic substituted piperidone compounds |
| 05/18/2006 | WO2006052190A1 Indazole sulphonamide derivatives |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006051390A1 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders, pharmaceutical compositions containing them, and methods of preparing them |
| 05/18/2006 | WO2006051312A1 Gastrin and cholecystokinin receptor ligands |
| 05/18/2006 | WO2006051311A1 Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes |
| 05/18/2006 | WO2006050998A1 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics |
| 05/18/2006 | WO2006023931A3 Kinase inhibitors |
| 05/18/2006 | WO2006012504A3 Compounds and methods for treatment of thrombosis |
| 05/18/2006 | WO2006010446A3 Medicinal use of receptor ligands |
| 05/18/2006 | WO2005082884A3 2-pyridin-2yl-pyrimidine derivatives useful in the treatment of gastro-esophagea l reflux disease |
| 05/18/2006 | WO2005032484A9 Alkoxy substituted imidazoquinolines |
| 05/18/2006 | US20060106232 atorvastatin hemi-calcium Form X and solvates of given powder X-ray diffraction pattern; small particle size distribution; dosage forms |
| 05/18/2006 | US20060106231 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/18/2006 | US20060106228 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106072 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors |
| 05/18/2006 | US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile |
| 05/18/2006 | US20060106062 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
| 05/18/2006 | US20060106061 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/18/2006 | US20060106058 Chemical compounds |
| 05/18/2006 | US20060106041 Synthesis of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole (YC-1) as anti-platelet agents |
| 05/18/2006 | US20060105997 Mitotic kinesin inhibitors |
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/18/2006 | US20060104907 Biologically potent analogues of the Dmt-Tic pharmacophore and methods of use |
| 05/18/2006 | DE102004055633A1 New 5-substituted quinoline and isoquinoline derivatives are glucocorticoid receptor binders useful for treating inflammatory diseases e.g. alveolitis, Sjogren's syndrome, atopic dermatitis, acute lymphatic leukemia, rhinitis and emesis |
| 05/18/2006 | DE102004054666A1 New substituted pyrazol-3-carboxamide derivatives useful to combat harmful plants and for growth regulation of plants |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/18/2006 | CA2586752A1 Substituted pyrrolidone compounds as ep4 agonists |
| 05/18/2006 | CA2585490A1 Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes |
| 05/17/2006 | EP1657239A2 Chromene compound |
| 05/17/2006 | EP1657238A1 Fused pyrimidine derivative and use thereof |
| 05/17/2006 | EP1656377A1 Aminobenzimidazole derivatives |
| 05/17/2006 | EP1656373A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokineantagonists |
| 05/17/2006 | EP1656372A2 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 05/17/2006 | EP1656369A1 Novel process for the preparation of 2h-chromenes |
| 05/17/2006 | EP1656355A2 Piperazine derivatives and methods of use |
| 05/17/2006 | EP1656353A1 Gabanergic modulators |
| 05/17/2006 | EP1656350A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 05/17/2006 | EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase |